Nagendra Singh, Remote - Live with Q&ASenior Scientist, Downstream Process Development at Catalent Cell & Gene Therapy, USA
Dr. Nagendra Singh has more than 10 years of R&D experience focused on preclinical protein and small molecule drug development. He is currently a Senior Scientist in the Downstream Process Development group within Catalent Cell and Gene Therapy. Nagendra leads and supports preclinical and early stage development and characterization of viral vectors for gene therapy. He holds a Ph.D. in Pharmaceutical Analysis from the University of Sunderland, UK and has completed postdoctoral research at the National Institute on Aging, NIH.